These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3494345)

  • 1. [Fibronectin and diseases in internal medicine].
    Backhaus M; Mielke F; Lukowsky A
    Z Arztl Fortbild (Jena); 1986; 80(21):883-7. PubMed ID: 3494345
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of fibronectin in plasma and synovial fluid from patients with rheumatoid arthritis and systemic lupus erythematosus ].
    Matsumoto Y; Imaizumi T; Kanie R
    Ryumachi; 1982 Jun; 22(3):240-3. PubMed ID: 7123399
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.
    Carsons S; Mosesson MW; Diamond HS
    Arthritis Rheum; 1981 Oct; 24(10):1261-7. PubMed ID: 6975631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin in plasma and synovial fluid of patients with rheumatic diseases.
    Duţu A; Vlaicu-Rus V; Boloşiu HD; Parasca I; Cristea A
    Med Interne; 1986; 24(1):61-8. PubMed ID: 3518030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relations between the antinuclear, rheumatoid and L.E.-cell factors in the systemic rheumatic diseases.
    HALL AP; BARDAWIL WA; BAYLES TB; MEDNIS AD; GALINS N
    N Engl J Med; 1960 Oct; 263():769-75. PubMed ID: 13710745
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibronectin and collagenosis].
    Villar M; Ordi J
    Med Clin (Barc); 1986 Sep; 87(9):371-3. PubMed ID: 3796137
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibronectin of the synovial fluid in rheumatoid arthritis].
    Daniiarova AS; Panasiuk AF
    Ter Arkh; 1985; 57(12):83-5. PubMed ID: 4089774
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional state of the blood coagulation system in patients with rheumatism and other collagenoses].
    Dashtaiants GA; Andrushchenko EV; Krasovskaia EA
    Vrach Delo; 1977 Jun; (6):32-4. PubMed ID: 302064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Labile globulins in the serum of patients with rheumatism and the major collagenoses].
    Kudriavtsev IuN
    Vopr Revm; 1971; 11(4):61-4. PubMed ID: 5316787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of blood viscosity in rheumatic diseases].
    Roques CF; Amigues H; Fournie A; Simon J; Guiraud R
    Nouv Presse Med; 1977 Sep; 6(30):2686. PubMed ID: 409995
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases.
    Sfikakis PP; Tsokos GC
    Clin Diagn Lab Immunol; 1997 May; 4(3):241-6. PubMed ID: 9144356
    [No Abstract]   [Full Text] [Related]  

  • 12. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.
    Cheema GS; Roschke V; Hilbert DM; Stohl W
    Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood viscosity in rheumatic diseases].
    Nasonova VA; Balabanova RM; Loskutova TT
    Revmatologiia (Mosk); 1984; (1):22-7. PubMed ID: 6371999
    [No Abstract]   [Full Text] [Related]  

  • 14. [Determination of synovial fibronectin by laser nephelometry. Its diagnostic value in rheumatology].
    North ML; Lecocq J; Roth-Fritsch M; Piffaut MC; Asch L
    Ann Biol Clin (Paris); 1985; 43(6):861-6. PubMed ID: 3879577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases.
    Oremek GM; Müller R; Sapoutzis N; Wigand R
    Anticancer Res; 2003; 23(2A):1131-4. PubMed ID: 12820360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex-formation with hyaluronic acid as a cause of fibronectin heterogeneity in the synovial fluid].
    Abdullin AR; Litvinov RI; Zinkevich OD; Zubairov DM; Salikhov IG
    Vopr Med Khim; 1987; 33(4):101-4. PubMed ID: 3660729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 18. Major microheterogeneity of alpha 1-acid glycoprotein in management of patients with rheumatic diseases.
    Mackiewicz A; Pawłowski T
    Prog Clin Biol Res; 1989; 300():219-22. PubMed ID: 2789388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma and synovial fibronectin. Results of personal research].
    Lecocq J; North ML; Grange D; Hauptmann G; Kuntz JL; Meyer R; Asch L
    Rev Rhum Mal Osteoartic; 1984; 51(7-8):393-8. PubMed ID: 6494778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of low molecular physiologically active substances in autoimmune diseases].
    Lysenko GI; Korolev IuN
    Vrach Delo; 1983 Dec; (12):29-32. PubMed ID: 6670231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.